BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 19528498)

  • 1. A role for the substance P/NK-1 receptor complex in cell proliferation in oral squamous cell carcinoma.
    Brener S; González-Moles MA; Tostes D; Esteban F; Gil-Montoya JA; Ruiz-Avila I; Bravo M; Muñoz M
    Anticancer Res; 2009 Jun; 29(6):2323-9. PubMed ID: 19528498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A role for the substance P/NK-1 receptor complex in cell proliferation and apoptosis in oral lichen planus.
    González Moles MA; Esteban F; Ruiz-Avila I; Gil Montoya JA; Brener S; Bascones-Martínez A; Muñoz M
    Oral Dis; 2009 Mar; 15(2):162-9. PubMed ID: 19036058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High stromal versican expression predicts unfavourable outcome in oral squamous cell carcinoma.
    Pukkila M; Kosunen A; Ropponen K; Virtaniemi J; Kellokoski J; Kumpulainen E; Pirinen R; Nuutinen J; Johansson R; Kosma VM
    J Clin Pathol; 2007 Mar; 60(3):267-72. PubMed ID: 16731595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurokinin-1 receptor (NK-1R) expression is induced in human colonic epithelial cells by proinflammatory cytokines and mediates proliferation in response to substance P.
    Goode T; O'Connor T; Hopkins A; Moriarty D; O'Sullivan GC; Collins JK; O'Donoghue D; Baird AW; O'Connell J; Shanahan F
    J Cell Physiol; 2003 Oct; 197(1):30-41. PubMed ID: 12942538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell proliferation associated with actions of the substance P/NK-1 receptor complex in keratocystic odontogenic tumours.
    González Moles MA; Mosqueda-Taylor A; Esteban F; Gil-Montoya JA; Díaz-Franco MA; Delgado M; Muñoz M
    Oral Oncol; 2008 Dec; 44(12):1127-33. PubMed ID: 18486533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of substance P and its receptor neurokinin-1 in psoriasis and their relation to chronic stress and pruritus.
    Remröd C; Lonne-Rahm S; Nordlind K
    Arch Dermatol Res; 2007 May; 299(2):85-91. PubMed ID: 17370082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The N-terminal domain of substance P is required for complete homologous desensitization but not phosphorylation of the rat neurokinin-1 receptor.
    Vigna SR
    Neuropeptides; 2001 Feb; 35(1):24-31. PubMed ID: 11346307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substance P receptor expression in human skin keratinocytes and fibroblasts.
    Liu JY; Hu JH; Zhu QG; Li FQ; Sun HJ
    Br J Dermatol; 2006 Oct; 155(4):657-62. PubMed ID: 16965412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression and altered subcellular localization of autophagy-related 16-like 1 in human oral squamous-cell carcinoma: correlation with lymphovascular invasion and lymph-node metastasis.
    Nomura H; Uzawa K; Yamano Y; Fushimi K; Ishigami T; Kouzu Y; Koike H; Siiba M; Bukawa H; Yokoe H; Kubosawa H; Tanzawa H
    Hum Pathol; 2009 Jan; 40(1):83-91. PubMed ID: 18789482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognosis value of the expression of Ki-67 for squamous cell carcinoma of the oral cavity.
    Gonzalez-Moles MA; Caballero R; Rodriguez-Archilla A; Ruiz-Avila I; Bravo I
    Acta Stomatol Belg; 1996 Dec; 93(4):159-65. PubMed ID: 9658636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nerve growth factor receptor (p75 NTR) and pattern of invasion predict poor prognosis in oral squamous cell carcinoma.
    Søland TM; Brusevold IJ; Koppang HS; Schenck K; Bryne M
    Histopathology; 2008 Jul; 53(1):62-72. PubMed ID: 18540978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurokinin-1 and neurokinin-3 receptors in primate substantia nigra.
    Lévesque M; Wallman MJ; Parent R; Sík A; Parent A
    Neurosci Res; 2007 Mar; 57(3):362-71. PubMed ID: 17134780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunolocalization of NK-1 receptor and Substance P in human normal placenta.
    Muñoz M; Pavón A; Rosso M; Salinas MV; Pérez A; Carranza A; González-Ortega A
    Placenta; 2010 Jul; 31(7):649-51. PubMed ID: 20430440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Investigation of CXCR4 in oral squamous cell carcinoma and its influence on proliferation of tumor cells in vitro].
    Xu M; Li WY; Chen XM; Wang XH; Huang J; Wang L
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2006 Jun; 41(6):372-5. PubMed ID: 16836911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increase in substance P precursor mRNA in noninflamed small-bowel sections in patients with Crohn's disease.
    Michalski CW; Autschbach F; Selvaggi F; Shi X; Di Mola FF; Roggo A; Müller MW; Di Sebastiano P; Büchler MW; Giese T; Friess H
    Am J Surg; 2007 Apr; 193(4):476-81. PubMed ID: 17368292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Observations favouring the occurrence of local production and marked effects of bombesin/gastrin-releasing peptide in the synovial tissue of the human knee joint--comparisons with substance P and the NK-1 receptor.
    Grimsholm O; Rantapää-Dahlqvist S; Dalén T; Forsgren S
    Neuropeptides; 2008 Apr; 42(2):133-45. PubMed ID: 18289674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of CXCR-4 expression in oral squamous cell carcinoma.
    Lee JI; Jin BH; Kim MA; Yoon HJ; Hong SP; Hong SD
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 May; 107(5):678-84. PubMed ID: 19272813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of neurotransmitter Substance P in progression of oral squamous cell carcinoma.
    Mehboob R; Tanvir I; Warraich RA; Perveen S; Yasmeen S; Ahmad FJ
    Pathol Res Pract; 2015 Mar; 211(3):203-7. PubMed ID: 25433994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacodiagnostic evaluation of EGFR expression in oral squamous cell carcinoma.
    Diniz-Freitas M; García-Caballero T; Antúnez-López J; Gándara-Rey JM; García-García A
    Oral Dis; 2007 May; 13(3):285-90. PubMed ID: 17448210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neonatal capsaicin treatment affects rat thymocyte proliferation and cell death by modulating substance P and neurokinin-1 receptor expression.
    Santoni G; Amantini C; Lucciarini R; Perfumi M; Pompei P; Piccoli M
    Neuroimmunomodulation; 2004; 11(3):160-72. PubMed ID: 15067207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.